Ozempic, or Semaglutide GLP-1, is primarily utilized in managing type 2 diabetes but has shown promising results in aiding weight loss when combined with a balanced diet and regular exercise
Semaglutide helps lower blood sugar partly by calming liver sugar production
therefore, if the increased lipid catabolism produces more acetyl-CoA for energy production, the portion of the acetyl-CoA sourced from other nutrients, such as glucose, would decrease correspondingly
If gastrointestinal symptoms are severe or persistent despite conservative measures, medical review is essential to exclude other pathology and consider alternative management approaches
A Cleveland Clinic team led by cardiologist Amgad Mentias, MD, recently published a large database analysis showing that bariatric surgery in Medicare enrollees with obesity was associated with lower risk of mortality, new-onset heart failure and myocardial infarction ( J Am Coll Cardiol